Medtronic (MDT) stock rises amid hopes for permanent Category I codes for renal denervation that can widen coverage for the company's Symplicity Spyral. Read more here.
Dulan Lokuwithana is an Editor for Breaking News at NewsBreak. He specializes in the intersection of finance and healthcare, covering topics such as pharmaceutical manufacturing, regulation, and advancements in gene therapy, immunology, and oncology. Dulan's insights and analyses are featured in prominent outlets like NewsBreak and Seeking Alpha.














